| Application no. and date | 18712044.9 (espacenet) (Federated) (European Patent Register), 20180228 | | Patent/reg. no. and date | DK/EP 3589661, 20231101 | | Publication date | 20200108 | | Priority no. and date | US 201762466239 P, 20170302, US 201762469317 P, 20170309, US 201762486876 P, 20170418 | | EP pub. no. and date |
EP 3589661 20200108 | | Effective date | | | Applicant/owner | Genentech, Inc., 1 DNA Way
South San Francisco,
CA 94080, US,
F. Hoffmann-La Roche AG, Grenzacherstrasse 124
4070 Basel, CH | | Applicant ref. no. | V469618DK00 | | Inventor | BENYUNES, Mark, C., c/o Genentech Inc.
1 DNA Way
South San Francisco, CA 94080, US,
ROSS, Graham, Alexander, 12 Digswell Road
Welwyn Garden City
Hertfordshire AL8 7PA, GB | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61K 39/395 (2006.01) , A61K 45/06 (2006.01) , A61K 9/00 (2006.01) , A61P 35/00 (2006.01) , C07K 16/32 (2006.01) | | Title | Adjuvansbehandling af HER2-positiv brystcancer | | Int. application no. | US2018020154 | | Int. publication no. | WO2018160654 | | Related patent (certificate) | | | Status | Rettet DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
